Status:
RECRUITING
Pain in Juvenile Arthritis
Lead Sponsor:
Washington University School of Medicine
Conditions:
Juvenile Idiopathic Arthritis
Eligibility:
All Genders
9-17 years
Phase:
NA
Brief Summary
Juvenile idiopathic arthritis (JIA) is the most common rheumatologic disease in children. The main symptoms of JIA, which are often the primary focus of treatment, include joint swelling, stiffness, a...
Eligibility Criteria
Inclusion
- Age between 9-17
- Males and females
- English speakers
- Able to complete surveys and understand study instructions
- Juvenile arthritis group: diagnosed or suspected of juvenile arthritis
- Control group: healthy
Exclusion
- Pregnancy or breastfeeding
- (Control Group) Diagnosed with a chronic pain condition
- (Control Group) Diagnosed with psychiatric condition including ADHD, anxiety, depression, etc.
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2035
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT07217782
Start Date
September 15 2025
End Date
September 1 2035
Last Update
October 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63017